Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study. Kister I, Spelman T, Alroughani R, Lechner-Scott J, Duquette P, Grand'Maison F, Slee M, Lugaresi A, Barnett M, Grammond P, et al. J Neurol Neurosurg Psychiatry. 2016 Jun 13. PMID: 27298148. Abstract CommentRecommendBookmarkWatch